Sr. No. Particulars Total Cost (Rs.)1 Repairs and ma<strong>in</strong>tenance 1,452,4002 Bus<strong>in</strong>ess Development expenses 500,0003 Lease rent for land 210,0004 Office Adm<strong>in</strong>istration and other misc. expenses 100,0005 Professional and legal fees 300,0006 Bank charges and commissions 20,0007 Pr<strong>in</strong>t<strong>in</strong>g and stationary 100,0008 Insurance and taxes 100,000Total Other Expenses 2,782,400E. Total Work<strong>in</strong>g CapitalParticulars Norms Total (Rs.)Raw Materials 2 Months of raw materials 5,250,667Pack<strong>in</strong>gMaterials2 Month of pack<strong>in</strong>g materials1,718,400F<strong>in</strong>ished Goods 1 Month of cost of production 3,961,867Bills Receivables 1 Month of sales value 4,773,333Outstand<strong>in</strong>gs 1 Month of Raw Material and Pack<strong>in</strong>g Material 3,484,533Total 12,219,733Note: 1. Work<strong>in</strong>g capital requirement <strong>in</strong>dicated above is at 100% capacity utilisation.2. Marg<strong>in</strong> money @ 25% of total Work<strong>in</strong>g Capital – Rs. 3,054,933CAPITAL INVESTMENTThe capital <strong>in</strong>vestment required for the project is Rs. 2.61 crore. The break-up of the capital<strong>in</strong>vestment is <strong>in</strong>dicated <strong>in</strong> below.Sr. No. Particulars Total Value (Rs.)1 Land and Site Development Cost 125,0002 Build<strong>in</strong>g and Civil Works 3,000,0003 Plant and Mach<strong>in</strong>ery 17,283,0004 Misc. Fixed Assets 195,0005 Prelim<strong>in</strong>ary and Pre-operative Expenses 310,0006 Provisions for Cont<strong>in</strong>gency 2,091,3007 Marg<strong>in</strong> Money for Work<strong>in</strong>g Capital 3,054,933Total Cost of the Project 26,059,233Debt and Equity StructureTotal Cost of ProjectPromoter’s Equity:Debt Funds:Rs. 26.06 lakhsRs. 10.42 alkhsRs. 15.64 lakhsFINANCIAL ANALYSISA. Cost of Production
Sr. No. Particulars Total (Rs.)1 Raw materials 31,504,0002 Pack<strong>in</strong>g materials 10,310,4003 Adm<strong>in</strong>istrative overheads 2,917,2004 Other overheads 1,470,0005 Interest on work<strong>in</strong>g capital 824,872Total cost of production 47,026,472Note: Cost of production <strong>in</strong>dicated above is at 100% capacity utilisation.B. TurnoverAnnual sales realisation of the manufactur<strong>in</strong>g unit with the assumed product mix is illustratedbelow. Sales realisation at 100% capacity utilisation are around Rs. 5.73 crores.Sr.No.ParticularsNo. of<strong>Capsule</strong>s(Lakhs)Sales Realisationper '000<strong>Capsule</strong>s (Rs.)Total SalesRealisation(Rs.)1 Tetracycl<strong>in</strong>e and Doxycycl<strong>in</strong>e 192 1,000 19,200,0002 Omeprazole (Antipeptic Ulcerants) 128 1,000 12,800,0003 Multi-vitam<strong>in</strong>s with m<strong>in</strong>erals 96 900 8,640,0004 Vitam<strong>in</strong> B complex 96 600 5,760,0005 Antianaemics with iron64 500 3,200,000comb<strong>in</strong>ations6 Antirheumatic 64 1,200 7,680,000Total 640 57,280,000Note: Total annual realisation mentioned above is at 100% capacity utilisationC. Profit and Loss Statement for 10 Years(Unit: Rs. lakhs)Particulars Formula Yr 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7 Yr 8 Yr 9 Yr 10Capacity Utilisation 25% 75% 100% 100% 100% 100% 100% 100% 100% 100%Sales Realisation A 95 430 573 573 573 573 573 573 573 573Operat<strong>in</strong>g Costs BRM and PM Costs 70 314 418 418 418 418 418 418 418 418Labour Costs 29 29 29 29 29 29 29 29 29 293. Other Overheads 5 12 15 15 15 15 15 15 15 15Interest on Work<strong>in</strong>gCapitalGross Profit <strong>in</strong>cl.Transport Subsidy1 6 8 8 8 8 8 8 8 8C=A-B -10 69 103 103 103 103 103 103 103 103Interest D 17 17 15 13 11 9 8 6 4 2Depreciation E 27 24 20 18 15 13 11 10 9 7PBT F=C-(D+E) -54 29 67 72 76 80 84 87 90 93Tax G 0 0 0 0 0 0 0 0 0 0PAT H=F-G -54 29 67 72 76 80 84 87 90 93Cash Profit I=H+E -27 52 88 89 91 93 95 97 99 101GP Marg<strong>in</strong> J=C/A -10% 16% 18% 18% 18% 18% 18% 18% 18% 18%NP Marg<strong>in</strong> K=H/A -57% 7% 12% 13% 13% 14% 15% 15% 16% 16%Note:1. Figures <strong>in</strong>dicated above are rounded-off2. Annual sales values <strong>in</strong>dicated above are after tak<strong>in</strong>g <strong>in</strong>to consideration open<strong>in</strong>g and clos<strong>in</strong>g stockReturn on <strong>Invest</strong>ment (ROI): 27%D. Breakeven AnalysisThe breakeven analysis for the proposed capsule-manufactur<strong>in</strong>g unit is <strong>in</strong>dicated below. The